secwatch.observer — SEC 8-K summary
======================================

Issuer:     ProtoKinetix, Inc. (PKTX)
CIK:        0001128189
Form:       8-K
Filed at:   2025-11-17T23:59:59+00:00
Accession:  0001079973-25-001778
Event type: leadership
Sentiment:  negative
Materiality: 0.80
Item codes: 5.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

ProtoKinetix CEO Clarence Smith dies in accident; CFO Guzzetta assumes all top roles
--------------------------------------------------------------------------------

- CEO Clarence E. Smith died Nov 13, 2025 in a tragic accident; served as CEO since 2015.
- Sole remaining director Ed McDonough appointed Michael Guzzetta as Chairman, CEO, President on Nov 16.
- Guzzetta continues as CFO, Secretary, Treasurer; his 2017 employment agreement unchanged.
- ProtoKinetix is a clinical-stage biomedical company (OTC: PKTX) with no disclosed financial impact.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1128189/000107997325001778/0001079973-25-001778-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1128189/000107997325001778/pktx_8k.htm
  HTML page:      https://secwatch.observer/filing/0001079973-25-001778

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer